Abstract
Viridans streptococci were the most common cause of bacteremia in 61 consecutive myeloablative allogeneic hematopoietic stem cell transplant (HSCT) recipients, occurring in 19 of 31 bacteremic patients (61%) during the period of post-transplant neutropenia. Seven of the 19 had more than one viridans streptococcus in the same blood culture. Twenty isolates from 15 patients were Streptococcus mitis. Most viridans streptococci were resistant to norfloxacin, used routinely for prophylaxis. Comparison of the 19 patients with viridans streptococcal bacteremia with a contemporaneous group of 23 allogeneic HSCT recipients with fever and neutropenia but no identified focus of infection found that patients with viridans streptococcal bacteremia were more likely to have severe intraoral pathology while neutropenic (26% vs 0%) and slightly shorter interval between the last dental procedure and the onset of neutropenia (11 vs 14 days). Poor underlying dental health and the use of norfloxacin thus appear to predispose to viridans streptococcal bacteremia. Bone Marrow Transplantation (2001) 27, 537–542.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Zinner SH . Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria Clin Infect Dis 1999 29: 490–494
Jones RN . Contemporary antimicrobial susceptibility patterns of bacterial pathogens commonly associated with febrile patients with neutropenia Clin Infect Dis 1999 29: 495–502
Feld R . Vancomycin as part of initial empirical antibiotic therapy for febrile neutropenia in patients with cancer: pros and cons Clin Infect Dis 1999 29: 503–507
Press O, Ramsey PG, Larson EB et al. Hickman catheter infections in patients with malignancies Medicine 1984 63: 189–200
Bochud P, Calandra T, Francioli P . Bacteremia due to viridans streptococci in neutropenic patients: a review Am J Med 1994 97: 256–264
Bochud P, Eggiman P, Calandra T et al. Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors Clin Infect Dis 1994 18: 25–31
Martino R, Manteiga R, Sanchez I et al. Viridans streptococcal shock syndrome during bone marrow transplantation Acta Haematol 1995 94: 69–73
Ruescher TJ, Sodeifi A, Scrivani SJ et al. The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies Cancer 1998 82: 2275–2281
Engelhard D, Elishoov H, Or R et al. Cytosine arabinoside as a major risk factor for Streptococcus viridans septicemia following bone marrow transplantation: a 5-year prospective study Bone Marrow Transplant 1995 16: 565–570
Mascret B, Maraninchi D, Gastaut JA et al. Risk factors for streptococcal septicemia after marrow transplantation Lancet 1984 1: 1185–1186
Kern W, Kurrle E, Schmeiser T . Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases Infection 1990 18: 138–145
Ruoff KL, Whiley RA, Beighton D . Streptococcus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (eds) Manual of Clinical Microbiology ASM Press: Washington, DC 1999 pp 283–296
Schei O, Waerhaug J, Lovdal A, Arno A . Alveolar bone loss as related to oral hygiene and age J Periodontol 1959 30: 7–16
Hirsch RP, Riegelman RK . Statistical First Aid: Interpretation of Health Research Data. 1st edn Blackwell Science; Cambridge, MA. 1992
Sparrelid E, Hagglund H, Remberger M et al. Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection Bone Marrow Transplant 1998 22: 795–800
Yuen KY, Woo PCY, Hui CH et al. Unique risk factors for bacteraemia in allogeneic bone marrow transplant recipients before and after engraftment Bone Marrow Transplant 1998 21: 1137–1143
Steiner M, Villablanca J, Kersey J et al. Viridans streptococcal shock in bone marrow transplantation patients Am J Hematol 1993 42: 354–358
Teoh-Chan CH, Cowlishaw A, Eley A et al. Laboratory evaluation of enoxacin: comparison with norfloxacin and nalidixic acid J Antimicrob Chemother 1985 15: 45–52
Haase D, Urias B, Harding G, Ronald A . Comparative in vitro activity of norfloxacin against urinary tract pathogens Eur J Clin Microbiol Infect Dis 1983 2: 235–241
Barry AL, Jones RN, Thornsberry C et al. In vitro activity of the aryl-fluoroquinolones A-56619 and A-56620 and evaluation of disk susceptibility tests Eur J Clin Microbiol Infect Dis 1986 5: 18–22
Carratala J, Alcaide F, Fernandez-Sevilla A et al. Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer Clin Infect Dis 1995 20: 1169–1173
Krcmery V, Trupl J . Bacteraemia due to penicillin-resistant Streptococcus viridans in cancer patients, before and after prophylaxis with penicillin Lancet 1995 346: 1362–1363
Gonzalez I, Georgiou M, Alcaide F et al. Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococci Antimicrob Agents Chemother 1998 42: 2792–2798
Peterson DE . Pretreatment strategies for infection prevention in chemotherapy patients NCI Monographs 1990 9: 61–71
National Institutes of Health Consensus Development Panel . Consensus statement: oral complications of cancer therapies NCI Monographs 1990 9: 3–8
Acknowledgements
The authors would like to thank Dr Daniel Fedorko and Dr Steve Yan of the Microbiology Service, Clinical Pathology Department, WG Magnuson Clinical Center for their efforts in obtaining norfloxacin suceptibilities for the majority of the isolates studied in this paper.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Graber, C., de Almeida, K., Atkinson, J. et al. Dental health and viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 27, 537–542 (2001). https://doi.org/10.1038/sj.bmt.1702818
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702818
Keywords
This article is cited by
-
Oral microbial changes and oral disease management before and after the treatment of hematological malignancies: a narrative review
Clinical Oral Investigations (2023)
-
Dental status and risk of odontogenic complication in patients undergoing hematopoietic stem cell transplant
Supportive Care in Cancer (2021)
-
The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy
Supportive Care in Cancer (2019)
-
A systematic review of dental disease management in cancer patients
Supportive Care in Cancer (2018)
-
Dental status does not predict infection during stem cell transplantation: a single-center survey
Bone Marrow Transplantation (2017)